GO
Loading...

Amylin Shares Hammered

Monday, 9 Jun 2008 | 3:25 PM ET

Shares of biopharma company Amylin are getting hammered over competitive fears being generated at the world's largest diabetes conference, reports CNBC's Mike Huckman.